in Newswire October 12, 2018

Class Action Lawsuit Alleges Chinese Companies Sold Valsartan Blood Pressure Medication ‘Adulterated’ with Carcinogen

by Corrado Rizzi

Last Updated on October 12, 2018

Gonteski v. Huahai Us, Inc. et al

Filed: October 11, 2018 § 3:18cv14858

Two Chinese companies face a class action over their alleged role in manufacturing and selling adulterated Valsartan, a blood pressure medication.



New Jersey

Last Updated on October 12, 2018 — 2:10 PM

Corrado Rizzi

Corrado Rizzi is the Managing Editor and a writer for

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.